Treatment Research Study for Cocaine Users
Researchers at Cove Behavioral Health are looking for individuals 18-65 years old who use cocaine regularly to participate in a study looking to better understand how we can help people reduce or stop their cocaine use. Join today!
Fast Facts
18-65 years old
looking to reduce cocaine use
Compensation Provided
Conducted in Tampa, FL
Study Background
Our researchers want to help you reduce your cocaine use through our treatment research study.
A variety of medication treatments for cocaine use have been explored, but so far there are no approved medications. Doctors are conducting the CURB-2 Study to better understand how we can help people reduce or stop their cocaine use.
This research evaluates the combination of 2 medications as a treatment. Other studies suggest that together these medications can help people reduce their cocaine use. This study includes the use of a placebo, which looks like the medication we are testing but does not include any active medicine.
Help advance cocaine treatment research by joining our study. Qualified participants will receive up to $1,603.
Study Background
Our researchers want to help you reduce your cocaine use through our treatment research study.
Cocaine use is a devastating problem in our nation. It attacks your brain and your body. It hurts both you and the people who care about you.
The purpose of our research study is to evaluate whether a combination of 2 medications reduces crack/cocaine use.
Help advance cocaine treatment research by joining our study. Qualified participants will receive up to $1,603.
Additional Information
You may qualify for this study if you meet the following criteria.
Key Criteria:
- Regularly use cocaine
- Are between the ages of 18-65
- Interested in stopping or reducing cocaine use
Participants in this study will receive a total of 5 injections over 8 weeks. Participants will be randomly assigned to receive either: 1) the two medications (Extended-Release Naltrexone (XR-NTX) + Extended-Release Buprenorphine (XR-BUP)) or 2) placebo injections.
